PCI
Clinical trials for PCI explained in plain language.
Never miss a new study
Get alerted when new PCI trials appear
Sign up with your email to follow new studies for PCI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New balloon technique takes on Rock-Hard arteries in heart disease trial
Disease control Recruiting nowThis study tests whether a super high-pressure balloon or a special shockwave device (intravascular lithotripsy) works better to crack open severely calcified coronary arteries before placing a stent. About 78 adults with hardened heart arteries will be randomly assigned to one o…
Matched conditions: PCI
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated May 17, 2026 06:22 UTC
-
Bypass or stents? major trial aims to settle best treatment for weak hearts
Disease control Recruiting nowThis study compares two common heart procedures—bypass surgery (CABG) and stents (PCI)—in 358 people with weak hearts (ejection fraction 40% or less) and multiple blocked arteries. The goal is to see which approach leads to better survival, fewer heart attacks or strokes, and imp…
Matched conditions: PCI
Phase: NA • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Heart stent study aims to find best way to fix recurrent blockages
Disease control Recruiting nowThis study compares two approaches for treating re-narrowed heart stents: using special imaging to guide the procedure versus standard X-ray guidance. About 1,500 people with a first-time re-blockage of a drug-coated stent will take part. The goal is to see which method leads to …
Matched conditions: PCI
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Diabetes drug may fight inflammation after stent procedure
Knowledge-focused Recruiting nowThis study tests whether empagliflozin, a diabetes drug, can reduce inflammation after a heart stent procedure. About 100 adults with stable coronary artery disease will take either empagliflozin or a placebo for three days before their scheduled stent placement. Researchers will…
Matched conditions: PCI
Phase: PHASE4 • Sponsor: Hotel Dieu de France Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC